bioAffinity Sets Nov 20 Vote on Warrant Exercises, $15M Offering Authority and Share-Count Cut
BIAF is trading near its 52-week low of $2.8 (0.4% above the low).
Summary
bioAffinity's definitive proxy sets a November 20, 2026 special meeting to approve warrant exercises worth up to about $11.6 million in gross proceeds, pre-authorization for up to $15 million of discounted private offerings, and a reduction in authorized shares from 350 million to 200 million.
Key Events · Financing and Capital Events · BIAF
-
Special Meeting Set for November 20
Stockholders of record on September 23, 2026 will vote on five proposals at an in-person meeting in San Antonio at 8:00 a.m. Central Time.
-
Warrant Votes Unlock Up to ~$11.6M
Approving the August warrants (1,128,272 shares at $4.9757) and October warrants (980,072 shares at $6.122) is a condition to receiving up to about $5.6 million and $6.0 million in gross proceeds if exercised for cash.
-
Heavy Dilution if Warrants Exercised
Full exercise would add 2,108,344 shares against 1,166,625 shares outstanding as of the September 23, 2026 record date.
-
New $15M Private-Offering Authority Sought
Proposal 3 would allow up to 10,000,000 shares and $15,000,000 in non-public offerings at discounts of up to 20% below market through November 20, 2027.
Analysis · BIAF · Industrial Applications And Services
This proxy puts hard numbers on the company's financing path. Approval of the August and October warrant proposals is the condition for bioAffinity to receive up to roughly $5.6 million and $6.0 million in gross proceeds if those warrants are exercised for cash — cash the company needs, given the going-concern warning and cash runway disclosed in the Q2 10-Q. Against that, full exercise would add 1,128,272 and 980,072 shares to a base of 1,166,625 shares outstanding, so existing holders face heavy dilution. Proposal 3 pre-authorizes up to 10,000,000 shares and $15,000,000 of non-public offerings at discounts of up to 20% below market through November 20, 2027, which keeps the door open for more dilution. Proposal 4, cutting authorized shares from 350,000,000 to 200,000,000, is largely cosmetic at this share count and does not offset the dilution from the warrant and offering proposals.
How filings like this one have moved
In the 30 days to Oct 24, 2026, 29.5% of the 1521 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.14%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BIAF was trading at $2.81 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3.6M. The 52-week trading range was $2.80 to $80.70. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.